Get started
Author

María José Bermejo

Observed names: M. J. Bermejo, M.J. Bermejo, Maria Bermejo, Maria J. Bermejo, Maria Jose Bermejo
ORCID: 0000-0002-6293-850X
Observed ORCID: 0000-0002-6293-850X
OpenAlex ID: A5073789406
Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study
2021 · Sofía Ruiz-Medina, Silvia Gil, et al. · Cancers · 35
Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HR+)/HER2-negative advanced breast cancer patients
2020 · Nuria Ribelles, Jose M. Jerez, et al. · European Journal of Cancer · 26
Epidermal growth factor receptors in human breast and endometrial carcinomas
1989 · M.A. Llorens, M.J. Bermejo, et al. · Journal of Steroid Biochemistry · 14
Abstract OT-03-07: Solti-1804 HER2-PREDICT: A biomarker research study of DS8201-A-U301 -U302 and -U303 trials
2021 · Aleix Prat, Joaquin Gavilá, et al. · Cancer Research · 2
403 Primary results from ENGOT-Ov41/GEICO 69-O/ANITA, a double-blind placebo-controlled phase 3 trial evaluating atezolizumab combined with platinum-based chemotherapy and maintenance niraparib for recurrent ovarian cancer with a platinum-free interval >6 months
2024 · Antonio González-Martín, Maria Jesús Rubio-Pérez, et al. · International Journal of Gynecological Cancer · 1
Association between antibiotic use and pathologic response to neoadjuvant chemotherapy in breast cancer: a multicentre retrospective cohort study
2026 · M. Zalabardo, I. Fernández, et al. · The Breast
Addressing unmet needs in long-term survivors of ovarian cancer (ENGOT ov40/NOGGO S13/GEICO 71-R/Expression VI): insights from a Spanish cohort
2026 · Maria-Pilar Barretina-Ginesta, Ainhoa Madariaga, et al. · International Journal of Gynecological Cancer
Association between Antibiotic Use and Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicentre Retrospective Cohort Study
2026 · Manuel Zalabardo Aguilar, Inés Fernández, et al. · SSRN Electronic Journal
Real-world data analysis of adjuvant capecitabine for triple-negative breast cancer after neoadjuvant chemotherapy
2025 · Ana Godoy-Ortíz, Gonzalo Lendínez-Sánchez, et al. · Frontiers in Oncology
PDF
P006: Retrospective Analysis of Adjuvant Capecitabine for Triple-Negative Breast Cancer After Preoperative Chemotherapy
2025 · G. Lendinez-Sanchez, A. Godoy-Ortiz, et al. · The Breast
Incidence and impact of adverse events in two hospitals
2005 · Jesús María Aranaz Andrés, Ramón Limón, et al.
Works count: 11
Citation count: 78
H-index: 3
I10-index: 3
Year
Topic
Type